At the core of UT MD Anderson¡¯s approach to exceptional patient care is a virtuous cycle of innovation that's grounded in collaboration, connectivity and data-based science. Our unique environment and vast resources accelerate novel concepts faster than ever before by offering leading scientific minds close proximity to our clinics to ease collaboration with our renowned clinicians and our patient partners.
At the American Association for Cancer Research Annual Meeting, our experts showcase their pacesetting research and join colleagues from across the globe for discussion on the latest advances in cancer science.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open research positions at UT MD Anderson.
Featured Articles
Meet the Experts
Visit us at Booth 2527 to discuss hot topics and emerging trends with leading minds in cancer science.
Exhibit Hall Hours
Sunday, April 27, 2025: noon¨C5 p.m.
Monday, April 28, 2025: 9 a.m.¨C5 p.m.
Tuesday, April 29, 2025: 9 a.m.¨C5 p.m.
Wednesday, April 30, 2025: 9 a.m.¨Cnoon
Barista-crafted coffee available at the booth during all hours of the exhibit hall.
Our research by the numbers
$1.3B
invested in research
140
patents awarded to UT MD Anderson in FY25
1,579
clinical trials in FY25
Education and Training at UT MD Anderson
UT MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to postdoctoral training.
Institutes at UT MD Anderson
United by a shared mission to end cancer, UT MD Anderson clinicians and scientists work seamlessly together to advance groundbreaking research that can transform the field of hematology. Leveraging our unique research ecosystem, including three leading institutes, we are pioneering new prevention, diagnostic and treatment approaches to address the most pressing needs for patients with cancer.
James P. Allison Institute
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Institute for Cell Therapy Discovery & Innovation
Building upon unparalleled expertise, UT MD Anderson¡¯s Institute for Cell Therapy Discovery & Innovation is leading the world in developing and advancing impactful cell therapies for patients in need. By uniting the top minds in the field to lead exceptional fundamental, translational and clinical research, we're focused on creating breakthrough off-the-shelf therapies that can be readily adapted for both hematologic and solid tumors as well as devastating auto-immune conditions, infections and other diseases.
Learn more about the Institute for Cell Therapy Discovery & Innovation
Institute for Data Science in Oncology
The Institute for Data Science in Oncology (IDSO) integrates the tremendous power of meaningful data extraction and interpretation with UT MD Anderson¡¯s unparalleled scientific and clinical expertise to transform research and care to impact patients.
